MGTA - Dianthus Therapeutics Inc
Close
0.71
0.710 100.000%
Share volume: 0
Last Updated: Mon 11 Sep 2023 09:11:22 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
5%
Profitability
0%
Dept financing
2%
Liquidity
50%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.43%
Return on assets
-12.76%
Return on sales
0%
Return on invested capital
-273.31%
Total debt ratio
9.24%
Debt ratio change over timeo
-1%
Current Ratio
14.96%
Quick Ratio
0%
Cash Position Ratio
7.38%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.1%
Return on assets
-13.31%
Return on sales
0%
Return on invested capital
-616.1%
Total debt ratio
10.86%
Debt ratio change over timeo
-1%
Current Ratio
13.9%
Quick Ratio
0%
Cash Position Ratio
8.13%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.97%
Return on assets
-10.49%
Return on sales
0%
Return on invested capital
-3966.53%
Total debt ratio
8.82%
Debt ratio change over time
-0.99%
Current Ratio
17.35%
Quick Ratio
0%
Cash Position Ratio
13.14%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.96%
Return on assets
-99.94%
Return on sales
0%
Return on invested capital
-70%
Total debt ratio
-100.08%
Debt ratio change over time
-1%
Current Ratio
-0.99%
Quick Ratio
0%
Cash Position Ratio
-0.77%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MGTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.43% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.76% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -273.31% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 9.24% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 13.9% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.13% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 33% | 33% |
| Short-term ratios | MGTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.1% | -25.62% | 17.94% | 7.14% |
| Return on assets | -13.31% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -616.1% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 10.86% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 13.9% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.13% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 21% | 36% |